Neogen Chemicals Limited Latest Updates

In late July 2026, Neogen Chemicals reported its financial results for the first quarter ended June 30, 2026 (Q1 FY27). Consolidated revenue from operations grew 34.0% year-on-year to ₹250.29 crore (total income rose 35.3% YoY to ₹254.15 crore). Consolidated net profit (PAT) jumped 66.8% YoY to ₹17.11 crore (up 50.2% sequentially from ₹11.39 crore in Q4 FY26), with operating margins expanding to approximately 19.3% on favorable product mix and operating efficiencies. Battery Materials & Neogen Ionics Execution Revenues from subsidiary Neogen Ionics surged to ₹19 crore in Q1 FY27 (up from ₹5 crore in Q1 FY26). Mechanical assembly of the dedicated electrolyte facility was completed with customer trial batches underway. Commercial commissioning for the electrolyte lines is scheduled for H1 FY27, followed by lithium electrolyte salts in H2 FY27. The company secured provisional qualifications from four international customers, while Japanese partner Morita's $20 million equity contribution toward the joint venture is slated for deployment in Q2–Q3 FY27. ₹600 Crore Fundraise Approval via QIP To finance ongoing capital expenditure across specialty organic bromides, lithium derivatives, and battery materials while managing balance-sheet leverage, the Board of Directors approved raising capital of up to ₹600 crore through a Qualified Institutional Placement (QIP). Annual Dividend & Shareholder Record Date The Board recommended a final equity dividend of ₹1.00 per equity share for FY25–26. The company established Thursday, August 13, 2026, as the formal record date to determine eligible shareholders for the final disbursement.